Review: taking Trileptal and Clonazepam together


Summary

Drug interactions are reported among people who take Trileptal and Clonazepam together. This review analyzes the effectiveness and drug interactions between Trileptal and Clonazepam. It is created by eHealthMe based on reports of 1,412 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Trileptal and Clonazepam >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Trileptal

Trileptal has active ingredients of oxcarbazepine. It is often used in epilepsy. (latest outcomes from Trileptal 13,252 users)

Clonazepam

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Clonazepam 47,672 users)

On Aug, 30, 2016

1,412 people who take Trileptal, Clonazepam are studied.


Number of reports submitted per year:

Trileptal and Clonazepam drug interactions.

Drug effectiveness over time:

Trileptal:
  • < 1 month: 28.0% - (2 of 7 people)
  • 1 - 6 months: 57.0% - (4 of 7 people)
  • 6 - 12 months: 37.0% - (3 of 8 people)
  • 1 - 2 years: 14.0% - (2 of 14 people)
  • 2 - 5 years: 27.0% - (3 of 11 people)
  • 5 - 10 years: 66.0% - (4 of 6 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 1 people)
Clonazepam:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 50.0% - (3 of 6 people)
  • 6 - 12 months: 55.0% - (5 of 9 people)
  • 1 - 2 years: 35.0% - (5 of 14 people)
  • 2 - 5 years: 72.0% - (13 of 18 people)
  • 5 - 10 years: 62.0% - (5 of 8 people)
  • 10+ years: 100.0% - (4 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Trileptal:
  • female: 39.0% - (17 of 43 people)
  • male: 25.0% - (4 of 16 people)
Clonazepam:
  • female: 65.0% - (30 of 46 people)
  • male: 37.0% - (6 of 16 people)

Drug effectiveness by age:

Trileptal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 33.0% - (1 of 3 people)
  • 10-19: 0.0% - (0 of 4 people)
  • 20-29: 22.0% - (2 of 9 people)
  • 30-39: 43.0% - (7 of 16 people)
  • 40-49: 45.0% - (5 of 11 people)
  • 50-59: 40.0% - (6 of 15 people)
  • 60+: 0.0% - (0 of 1 people)
Clonazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 33.0% - (1 of 3 people)
  • 10-19: 25.0% - (1 of 4 people)
  • 20-29: 50.0% - (5 of 10 people)
  • 30-39: 58.0% - (10 of 17 people)
  • 40-49: 66.0% - (8 of 12 people)
  • 50-59: 71.0% - (10 of 14 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • coma
  • confusional state
  • fatigue
  • headache
  • hyponatraemia
  • hypotension
  • suicide attempt
  • tremor
  • adrenal carcinoma
  • anxiety
1 - 6 months:
  • convulsion
  • acne
  • confusional state
  • headache
  • vision blurred
  • angioneurotic oedema
  • asthenia
  • fatigue
  • hyponatraemia
  • mania
6 - 12 months:
  • anxiety
  • blood sodium decreased
  • loss of consciousness
  • white blood cell count decreased
  • dizziness
  • fatigue
  • hypoaesthesia
  • irritability
  • mean cell haemoglobin increased
  • monocyte count increased
1 - 2 years:
  • dyslipidaemia
  • type 2 diabetes mellitus
  • weight increased
  • abdominal pain upper
  • chest pain
  • diabetes mellitus inadequate control
  • diabetes with hyperosmolarity
  • diabetic foot
  • hepatitis c
  • hypertriglyceridaemia
2 - 5 years:
  • weight increased
  • hypoaesthesia
  • diabetes mellitus
  • paraesthesia
  • suicide attempt
  • vision blurred
  • anxiety
  • headache
  • diabetic coma
  • diabetic ketoacidosis
5 - 10 years:
  • emotional disorder
  • fatigue
  • hypersexuality
  • lipoatrophy
  • post-traumatic epilepsy
  • stretch marks
  • weight gain - unintentional
  • mental status changes
  • buffalo hump
  • diabetes mellitus non insulin-dependent
10+ years:
  • osteopenia
  • sleepiness
  • anxiety disorder
  • depression
  • hypomagnesemia
  • panic attack
  • sleep disorder due to general medical condition, insomnia type
not specified:
  • weight increased
  • convulsion
  • diabetes mellitus
  • depression
  • headache
  • nausea
  • dizziness
  • drug ineffective
  • fatigue
  • type 2 diabetes mellitus

Most common drug interactions by gender *:

female:
  • weight increased
  • headache
  • depression
  • convulsion
  • dizziness
  • diabetes mellitus
  • fatigue
  • nausea
  • drug ineffective
  • anxiety
male:
  • convulsion
  • diabetes mellitus
  • nausea
  • type 2 diabetes mellitus
  • dizziness
  • depression
  • vomiting
  • headache
  • somnolence
  • feeling abnormal

Most common drug interactions by age *:

0-1:
  • hypotonia
  • pancreatitis
  • apnoea
  • bradycardia
  • clonus
  • convulsion
  • convulsion neonatal
  • decreased activity
  • diabetes mellitus
  • drug exposure during pregnancy
2-9:
  • convulsion
  • dehydration
  • blood magnesium increased
  • blood potassium increased
  • blood pressure decreased
  • bronchopneumonia
  • cardiac failure
  • cough
  • croup infectious
  • death
10-19:
  • convulsion
  • weight increased
  • status epilepticus
  • depression
  • drug ineffective
  • somnolence
  • suicidal ideation
  • aggression
  • lethargy
  • anger
20-29:
  • headache
  • dizziness
  • suicidal ideation
  • diabetes mellitus
  • anger
  • asthenia
  • confusional state
  • dyspnoea
  • weight increased
  • abdominal pain
30-39:
  • weight increased
  • depression
  • completed suicide
  • diabetes mellitus
  • type 2 diabetes mellitus
  • vomiting
  • diabetes mellitus inadequate control
  • headache
  • nausea
  • somnolence
40-49:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • nausea
  • weight increased
  • fatigue
  • diabetes mellitus inadequate control
  • headache
  • dizziness
  • psychotic disorder
  • anxiety
50-59:
  • weight increased
  • headache
  • dizziness
  • nausea
  • depression
  • pain
  • type 2 diabetes mellitus
  • diabetes mellitus
  • vomiting
  • feeling abnormal
60+:
  • fall
  • dizziness
  • drug ineffective
  • anxiety
  • ataxia
  • convulsion
  • fatigue
  • pain
  • osteoarthritis
  • anaemia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Trileptal and Clonazepam?

Can you answer these questions?

More questions for: Trileptal, Clonazepam

You may be interested in these reviews

More reviews for: Trileptal, Clonazepam

On eHealthMe, Trileptal (oxcarbazepine) is often used to treat epilepsy. Clonazepam (clonazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.